Abstract
Prioritizing dataset dependability, model performance, and interoperability is a compelling demand for improving stroke risk prediction from medical surveys using AI in healthcare. These collective efforts are required to enhance the field of stroke risk assessment and demonstrate the transformational potential of AI in healthcare. This novel study leverages the CDC’s recently published 2022 BRFSS dataset to explore AI-based stroke risk prediction. Numerous substantial and notable contributions have been established from this study. To start with, the dataset’s dependability is improved through a unique RF-based imputation technique that overcomes the challenges of missing data. In order to identify the most promising models, six different AI models are meticulously evaluated including DT, RF, GNB, RusBoost, AdaBoost, and CNN. The study combines top-performing models such as GNB, RF, and RusBoost using fusion approaches such as soft voting, hard voting, and stacking to demonstrate the combined prediction performance. The stacking model demonstrated superior performance, achieving an F1 score of 88%. The work also employs Explainable AI (XAI) approaches to highlight the subtle contributions of important dataset features, improving model interpretability. The comprehensive approach to stroke risk prediction employed in this study enhanced dataset reliability, model performance, and interpretability, demonstrating AI’s fundamental impact in healthcare.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
simonbinakter8{at}gmail.com
sumyaakter601{at}gmail.com
The tittle has been updated nothing else.
Data Availability
The Behavioural Risk Factor Surveillance System (BRFSS)2022 dataset was used in this study,